RIPK1 and brain injury: In an independent study exploring ischemic brain injury, Nec—1, a selective inhibitor of RIPK1 kinase activity, was found to inhibit RIPK3/MLKL—dependent necroptotic signaling by impeding RIPK1 phosphorylation at Ser166.